TY  - GEN
AU  - Drenberg,Christina D
AU  - Shelat,Anang
AU  - Dang,Jinjun
AU  - Cotton,Anitria
AU  - Orwick,Shelley J
AU  - Li,Mengyu
AU  - Jeon,Jae Yoon
AU  - Fu,Qiang
AU  - Buelow,Daelynn R
AU  - Pioso,Marissa
AU  - Hu,Shuiying
AU  - Inaba,Hiroto
AU  - Ribeiro,Raul C
AU  - Rubnitz,Jeffrey E
AU  - Gruber,Tanja A
AU  - Guy,R Kiplin
AU  - Baker,Sharyn D
TI  - A high-throughput screen indicates gemcitabine and JAK inhibitors may be useful for treating pediatric AML
SN  - 2041-1723
PY  - 2019///0607
KW  - Adult
KW  - Animals
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - pharmacology
KW  - Bone Marrow
KW  - pathology
KW  - Bone Marrow Transplantation
KW  - Cell Line, Tumor
KW  - Child
KW  - Child, Preschool
KW  - Cytarabine
KW  - Deoxycytidine
KW  - analogs & derivatives
KW  - Disease-Free Survival
KW  - Female
KW  - High-Throughput Screening Assays
KW  - methods
KW  - Humans
KW  - Infant
KW  - Janus Kinase Inhibitors
KW  - Leukemia, Experimental
KW  - drug therapy
KW  - Leukemia, Myeloid, Acute
KW  - Male
KW  - Mice
KW  - Mice, Inbred C57BL
KW  - Mice, Transgenic
KW  - Taxoids
KW  - Whole-Body Irradiation
KW  - adverse effects
KW  - Xenograft Model Antitumor Assays
KW  - Young Adult
KW  - Gemcitabine
N1  - Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1038/s41467-019-09917-0
ER  -